(Q47138585)
Statements
1 reference
1 reference
29 December 2023
Development of a nanoliposomal formulation of erlotinib for lung cancer and in vitro/in vivo antitumoral evaluation (English)
1 reference
Xiao Zhou
1 reference
Hui Tao
1 reference
Kai-Hu Shi
1 reference
18 December 2017
1 reference
12
1 reference
1-8
1 reference
1 December 2017
1 reference
Identifiers
1 reference